JW
Therapeutic Areas
Veradermics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| VDPHL01 | Pattern Hair Loss (Androgenetic Alopecia) in Males and Females | Phase 3 |
| Exploratory Asset | Alopecia Areata | Exploratory/Pre-clinical |
Leadership Team at Veradermics
RW
Reid Waldman, MD
Chief Executive Officer and Board Member
TD
Tim Durso, MD
Chief Technical Officer
DC
Dominic Carrano, CPA
Chief Financial Officer and Treasurer
MN
Mark Neumann
Chief Commercial and Strategy Officer
VC
Vlad Coric, MD
Board of Directors
PE
Patrick Enright
Board of Directors